SBC Medical Group Holdings Incorporated (SBCWW) 10-Year Financial Performance & Capital Metrics

SBCWW • • Industrial / General

IndustrialsConsulting ServicesSpecialized Niche ConsultingHealthcare & Education Consultants

AboutSBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.Show more

Revenue $205M +6.1%
EBITDA $74M -10.6%
Net Income $47M +18.4%
EPS (Diluted) 0.48 +14.3%
Gross Margin 75.97% +7.1%
EBITDA Margin 36.07% -15.8%
Operating Margin 34.23% -6.3%
Net Margin 22.69% +11.6%
ROE 27.51% -12.1%
ROIC 72.31% -7.3%
Debt/Equity 0.06 -60.6%
Interest Coverage 2484.23 +59.2%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 21.6%
✓Strong Piotroski F-Score: 8/9
✓FCF machine: 25.3% free cash flow margin
✓Momentum leader: RS Rating 86 (top 14%)
✓Healthy 5Y average net margin of 15.6%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-20.1%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-20.39%

EPS CAGR

10Y-

5Y-

3Y-

TTM426.35%

ROCE

10Y Avg34.23%

5Y Avg34.23%

3Y Avg34.23%

Latest37.87%

Peer Comparison

Healthcare & Education Consultants

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HURNHuron Consulting Group Inc.	3.2B	185.58	29.60	9.11%	6.66%	21.68%	6.02%	0.71
SBCSBC Medical Group Holdings Incorporated	462.62M	4.51	9.34	6.13%	24.28%	17.47%	3.71%	0.06
SBCWWSBC Medical Group Holdings Incorporated		0.25	0.52	6.13%	24.28%	17.47%		0.06
RYOJrYojbaba Co., Ltd. Common Shares	37.46M	3.33		5.6%	11.51%	68.18%	1.82%	4.12

Profit & Loss

	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	174.16M	193.54M	205.42M
Revenue Growth %	-	0.11%	0.06%
Cost of Goods Sold+	59.33M	56.24M	49.37M
COGS % of Revenue	0.34%	0.29%	0.24%
Gross Profit+	114.83M	137.3M	156.05M
Gross Margin %	0.66%	0.71%	0.76%
Gross Profit Growth %	-	0.2%	0.14%
Operating Expenses+	94.72M	66.64M	85.75M
OpEx % of Revenue	0.54%	0.34%	0.42%
Selling, General & Admin	93.48M	66.23M	70.69M
SG&A % of Revenue	0.54%	0.34%	0.34%
Research & Development	0	0	0
R&D % of Revenue	-	-	-
Other Operating Expenses	1.23M	409.03K	15.06M
Operating Income+	20.12M	70.66M	70.3M
Operating Margin %	0.12%	0.37%	0.34%
Operating Income Growth %	-	2.51%	-0.01%
EBITDA+	26.05M	82.91M	74.1M
EBITDA Margin %	0.15%	0.43%	0.36%
EBITDA Growth %	-	2.18%	-0.11%
D&A (Non-Cash Add-back)	5.93M	12.25M	3.8M
EBIT	23.71M	73.63M	73.48M
Net Interest Income+	440.94K	41.46K	-8.36K
Interest Income	472.38K	86.75K	19.94K
Interest Expense	31.44K	45.29K	28.3K
Other Income/Expense	3.56M	2.92M	3.15M
Pretax Income+	23.68M	73.58M	73.46M
Pretax Margin %	0.14%	0.38%	0.36%
Income Tax+	18.12M	35.02M	26.77M
Effective Tax Rate %	0.27%	0.54%	0.63%
Net Income+	6.32M	39.37M	46.61M
Net Margin %	0.04%	0.2%	0.23%
Net Income Growth %	-	5.23%	0.18%
Net Income (Continuing)	5.55M	38.56M	46.69M
Discontinued Operations	0	0	0
Minority Interest	2.6M	1.65M	-87K
EPS (Diluted)+	0.04	0.42	0.48
EPS Growth %	-	10.44%	0.14%
EPS (Basic)	0.04	0.42	0.48
Diluted Shares Outstanding	15.07M	94.19M	96.56M
Basic Shares Outstanding	15.07M	94.19M	96.56M
Dividend Payout Ratio	-	-	-

Balance Sheet

	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	112.95M	165.91M	184.45M
Cash & Short-Term Investments	53.64M	103.02M	125.04M
Cash Only	51.74M	103.02M	125.04M
Short-Term Investments	1.91M	0	0
Accounts Receivable	43.65M	53.13M	48.19M
Days Sales Outstanding	91.47	100.2	85.63
Inventory	1.35M	3.09M	1.49M
Days Inventory Outstanding	8.31	20.06	11.05
Other Current Assets	37.23K	162.12K	25.54K
Total Non-Current Assets+	112.53M	92.9M	81.63M
Property, Plant & Equipment	21.51M	19.5M	14.04M
Fixed Asset Turnover	8.10x	9.92x	14.63x
Goodwill	3.87M	3.59M	4.61M
Intangible Assets	7.27M	19.74M	1.59M
Long-Term Investments	916.03K	20.66M	20.87M
Other Non-Current Assets	73.7M	29.41M	30.72M
Total Assets+	225.48M	258.81M	266.08M
Asset Turnover	0.77x	0.75x	0.77x
Asset Growth %	-	0.15%	0.03%
Total Current Liabilities+	101.25M	92.45M	61.19M
Accounts Payable	15.32M	26.53M	14.53M
Days Payables Outstanding	94.26	172.2	107.46
Short-Term Debt	4.76M	3.53M	123.08K
Deferred Revenue (Current)	1000K	1000K	1000K
Other Current Liabilities	25.2M	832.52K	227.89K
Current Ratio	1.12x	1.79x	3.01x
Quick Ratio	1.10x	1.76x	2.99x
Cash Conversion Cycle	5.52	-51.94	-10.78
Total Non-Current Liabilities+	16.38M	22.54M	9.87M
Long-Term Debt	5.53M	13.01M	6.51M
Capital Lease Obligations	2.36M	2.44M	1.24M
Deferred Tax Liabilities	7.34M	6.01M	926.02K
Other Non-Current Liabilities	1.15M	1.07M	1.19M
Total Liabilities	117.63M	115M	71.06M
Total Debt+	16.13M	22.87M	12.21M
Net Debt	-35.61M	-80.16M	-112.83M
Debt / Equity	0.15x	0.16x	0.06x
Debt / EBITDA	0.62x	0.28x	0.16x
Net Debt / EBITDA	-1.37x	-0.97x	-1.52x
Interest Coverage	639.85x	1560.10x	2484.23x
Total Equity+	107.85M	143.81M	195.02M
Equity Growth %	-	0.33%	0.36%
Book Value per Share	7.16	1.53	2.02
Total Shareholders' Equity	105.25M	142.16M	195.11M
Common Stock	0	9.42K	10.3K
Retained Earnings	103.48M	142.85M	189.46M
Treasury Stock	0	0	-2.7M
Accumulated OCI	-24.85M	-37.58M	-54.18M
Minority Interest	2.6M	1.65M	-87K

Cash Flow

	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-47.37K	50.67M	55.34M
Operating CF Margin %	-0%	0.26%	0.27%
Operating CF Growth %	-	1070.69%	0.09%
Net Income	5.55M	38.56M	46.61M
Depreciation & Amortization	5.93M	12.25M	3.8M
Stock-Based Compensation	0	0	0
Deferred Taxes	-3.9M	4.11M	-14.42M
Other Non-Cash Items	2.96M	3.4M	31.47M
Working Capital Changes	-10.59M	-7.65M	-12.13M
Change in Receivables	-9.6M	-6.01M	13.1M
Change in Inventory	-666.64K	-1.83M	1.12M
Change in Payables	172.61K	12.2M	-8.91M
Cash from Investing+	-32.65M	1.79M	-10.1M
Capital Expenditures	-24.95M	-9.52M	-3.41M
CapEx % of Revenue	0.14%	0.05%	0.02%
Acquisitions	-	-	-
Investments	-	-	-
Other Investing	1.43M	8.6M	-1.29M
Cash from Financing+	-7.98M	6.14M	-11.79M
Debt Issued (Net)	-	-	-
Equity Issued (Net)	-	-	-
Dividends Paid	0	0	0
Share Repurchases	-	-	-
Other Financing	-2.89M	2.56M	11.71M
Net Change in Cash	-	-	-
Free Cash Flow+	-24.99M	39.46M	51.93M
FCF Margin %	-0.14%	0.2%	0.25%
FCF Growth %	-	2.58%	0.32%
FCF per Share	-1.66	0.42	0.54
FCF Conversion (FCF/Net Income)	-0.01x	1.29x	1.19x
Interest Paid	31.44K	45.29K	0
Taxes Paid	30.82M	17.84M	0

Key Ratios

Metric	2022	2023	2024
Return on Equity (ROE)	5.86%	31.29%	27.51%
Return on Invested Capital (ROIC)	20.89%	77.99%	72.31%
Gross Margin	65.94%	70.94%	75.97%
Net Margin	3.63%	20.34%	22.69%
Debt / Equity	0.15x	0.16x	0.06x
Interest Coverage	639.85x	1560.10x	2484.23x
FCF Conversion	-0.01x	1.29x	1.19x
Revenue Growth	-	11.13%	6.13%

Frequently Asked Questions

Valuation & Price

SBC Medical Group Holdings Incorporated (SBCWW) has a price-to-earnings (P/E) ratio of 0.5x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

SBC Medical Group Holdings Incorporated (SBCWW) reported $178.5M in revenue for fiscal year 2024. This represents a 2% increase from $174.2M in 2022.

SBC Medical Group Holdings Incorporated (SBCWW) grew revenue by 6.1% over the past year. This is steady growth.

Yes, SBC Medical Group Holdings Incorporated (SBCWW) is profitable, generating $43.3M in net income for fiscal year 2024 (22.7% net margin).

Dividend & Returns

SBC Medical Group Holdings Incorporated (SBCWW) has a return on equity (ROE) of 27.5%. This is excellent, indicating efficient use of shareholder capital.

SBC Medical Group Holdings Incorporated (SBCWW) had negative free cash flow of $36.6M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener